AR049846A1 - Preparaciones farmaceuticas de derivados de la piperazina - Google Patents

Preparaciones farmaceuticas de derivados de la piperazina

Info

Publication number
AR049846A1
AR049846A1 ARP050102897A ARP050102897A AR049846A1 AR 049846 A1 AR049846 A1 AR 049846A1 AR P050102897 A ARP050102897 A AR P050102897A AR P050102897 A ARP050102897 A AR P050102897A AR 049846 A1 AR049846 A1 AR 049846A1
Authority
AR
Argentina
Prior art keywords
preservative
pharmaceutical preparations
piperazine derivatives
preservatives
less
Prior art date
Application number
ARP050102897A
Other languages
English (en)
Inventor
Domenico Fanara
Jean Scouvart
Claire Poulain
Michel Deleers
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34925743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR049846(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of AR049846A1 publication Critical patent/AR049846A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Preparacion líquida que contiene un principio activo perteneciente a la familia de las benzhidril piperazinas sustituidas con cantidades reducidas de conservantes. Reivindicacion 1: Una preparacion farmacéutica líquida que contiene un principio activo elegido entre cetirizina, levocetirizina y efletirizina, y al menos un conservante, donde la cantidad de conservante es en el caso de los ésteres de parahidroxibenzoato superior a 0 e inferior a 1,5 mg/ml de la preparacion, y en el caso de otros conservantes es tal que produce los mismos efectos conservantes que una concentracion de ésteres de parahidroxibenzoato superior a 0 e inferior a 1,5 mg/ml.
ARP050102897A 2004-07-14 2005-07-13 Preparaciones farmaceuticas de derivados de la piperazina AR049846A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04016519 2004-07-14

Publications (1)

Publication Number Publication Date
AR049846A1 true AR049846A1 (es) 2006-09-06

Family

ID=34925743

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102897A AR049846A1 (es) 2004-07-14 2005-07-13 Preparaciones farmaceuticas de derivados de la piperazina

Country Status (26)

Country Link
US (1) US8633194B2 (es)
EP (1) EP1768649B1 (es)
JP (1) JP4902875B2 (es)
KR (1) KR101185612B1 (es)
CN (1) CN100508981C (es)
AR (1) AR049846A1 (es)
AT (1) ATE443512T1 (es)
AU (1) AU2005261953B2 (es)
BR (1) BRPI0513257C1 (es)
CA (1) CA2573662A1 (es)
CY (1) CY1109670T1 (es)
DE (1) DE602005016802D1 (es)
EA (1) EA012463B1 (es)
ES (1) ES2332462T3 (es)
HK (1) HK1103958A1 (es)
IL (1) IL180010A0 (es)
MX (1) MX2007000230A (es)
MY (1) MY149403A (es)
NO (1) NO337768B1 (es)
NZ (1) NZ552182A (es)
PE (1) PE20060484A1 (es)
PL (1) PL1768649T3 (es)
PT (1) PT1768649E (es)
TW (1) TWI304339B (es)
WO (1) WO2006005507A2 (es)
ZA (1) ZA200700939B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2408453B1 (en) 2009-03-17 2022-01-05 Nicox Ophthalmics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
TWI503122B (zh) * 2012-02-15 2015-10-11 Taiho Pharmaceutical Co Ltd Oral administration of pharmaceutical compositions
KR102155836B1 (ko) 2013-02-22 2020-09-14 삼성전자주식회사 터치 스크린 상에서 객체 디스플레이를 제어하는 휴대 단말 및 방법
US11241426B2 (en) * 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
CN113712907A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种盐酸左西替利嗪滴眼液组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255358A (en) * 1978-03-13 1981-03-10 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Process for the production of hexanitrostilbene
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5504113A (en) * 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
EP0785780A1 (en) * 1994-10-10 1997-07-30 Novartis AG Ophthalmic and aural compositions containing diclofenac potassium
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
US6432961B1 (en) * 1998-08-18 2002-08-13 Ucb S.A. Method for preventing the onset of asthma
AUPQ419099A0 (en) * 1999-11-23 1999-12-16 Ko, Thomas Sai Ying Novel compositions and methods
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002047689A2 (en) 2000-12-15 2002-06-20 Ucb, S.A. Use of cetirizine or efletirizine for preventing urticaria
US6869618B2 (en) * 2001-04-10 2005-03-22 Kiel Laboratories, Inc. Process for preparing tannate liquid and semi-solid dosage forms
CN1867336B (zh) * 2002-06-12 2010-05-12 凯莫森特里克斯股份有限公司 1-芳基-4-取代的哌嗪衍生物及其制药用途
WO2004004705A2 (en) 2002-07-03 2004-01-15 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
PT1569650E (pt) 2002-12-03 2008-06-26 Ucb Farchim Sa Utilização de levocetirizina para o tratamento da rinite alérgica persistente
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US20090137645A1 (en) * 2007-10-31 2009-05-28 Midlothian Laboratories, Llc Shelf-Stable Famotidine Granulates for Oral Suspensions

Also Published As

Publication number Publication date
NO337768B1 (no) 2016-06-20
HK1103958A1 (en) 2008-01-04
IL180010A0 (en) 2007-05-15
MX2007000230A (es) 2007-03-30
DE602005016802D1 (de) 2009-11-05
EA012463B1 (ru) 2009-10-30
ES2332462T3 (es) 2010-02-05
NO20070832L (no) 2007-02-13
CN100508981C (zh) 2009-07-08
JP2008505949A (ja) 2008-02-28
CN1984641A (zh) 2007-06-20
PE20060484A1 (es) 2006-07-06
ZA200700939B (en) 2008-08-27
CY1109670T1 (el) 2014-08-13
WO2006005507A3 (en) 2006-04-27
BRPI0513257A (pt) 2008-04-29
TWI304339B (en) 2008-12-21
WO2006005507A8 (en) 2006-12-07
US20070275974A1 (en) 2007-11-29
US8633194B2 (en) 2014-01-21
EP1768649A2 (en) 2007-04-04
AU2005261953B2 (en) 2010-06-03
TW200605892A (en) 2006-02-16
WO2006005507A2 (en) 2006-01-19
BRPI0513257B1 (pt) 2018-05-29
EA200700067A1 (ru) 2007-08-31
NZ552182A (en) 2010-07-30
EP1768649B1 (en) 2009-09-23
AU2005261953A1 (en) 2006-01-19
JP4902875B2 (ja) 2012-03-21
ATE443512T1 (de) 2009-10-15
BRPI0513257C1 (pt) 2021-05-25
CA2573662A1 (en) 2006-01-19
MY149403A (en) 2013-08-30
KR101185612B1 (ko) 2012-09-24
KR20070043841A (ko) 2007-04-25
PL1768649T3 (pl) 2010-02-26
PT1768649E (pt) 2009-11-13

Similar Documents

Publication Publication Date Title
AR049846A1 (es) Preparaciones farmaceuticas de derivados de la piperazina
WO2005110398A3 (en) Pharmaceutical solution formulations containing 17-aag
EP1243524A3 (en) Pharmaceutical kit for oxygen-sensitive drugs
ES2169087T3 (es) Formulaciones orales de un antifungico.
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
PE20050438A1 (es) Formulas farmaceuticas, metodos y regimenes de dosificacion para el tratamiento y la prevencion de sindromes coronarios agudos
SE0003449D0 (sv) Anticancer compositions
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
UA102478C2 (en) Capsule composition
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
DE60312523D1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
RS52367B (en) GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES
EA201100430A1 (ru) Стабильная комбинированная фармацевтическая композиция
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
AR034370A1 (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral
EA200601901A1 (ru) Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием
BRPI0511387A (pt) composição e seu uso
EA200401298A1 (ru) Жидкие фармацевтические композиции, содержащие низкую дозу энтекавира, и их применение
ECSP044979A (es) Uso de bibn4096 en combinación con otros fármacos antimigrañosos para el tratamiento de migraña
PT1414467E (pt) Tratamento topico da mastalgia
AR042598A1 (es) Composiciones de acetaminofeno
ATE400256T1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
ES2197781B1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
BR0214487A (pt) Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes

Legal Events

Date Code Title Description
FA Abandonment or withdrawal